Cargando…
Cancer screening and prevention in BRCA mutation carriers: a missed opportunity?
While the elevated lifetime risk of breast and ovarian cancer is well recognised for patients with a BRCA mutation, the implementation of effective risk reduction strategies has been fraught with challenges. This report from an international database and published in the British Journal of Cancer re...
Autores principales: | LeVasseur, Nathalie, Chia, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738056/ https://www.ncbi.nlm.nih.gov/pubmed/31171836 http://dx.doi.org/10.1038/s41416-019-0484-8 |
Ejemplares similares
-
Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018) -
Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?
por: LeVasseur, N, et al.
Publicado: (2017) -
A new paradox for pCR in BRCA mutation carriers
por: Rounis, Konstantinos, et al.
Publicado: (2019) -
Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010) -
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
por: Pataky, Reka, et al.
Publicado: (2013)